Literature DB >> 24046390

Risk factors for inflammatory breast cancer and other invasive breast cancers.

Catherine Schairer1, Yan Li, Peter Frawley, Barry I Graubard, Robert D Wellman, Diana S M Buist, Karla Kerlikowske, Tracy L Onega, William F Anderson, Diana L Miglioretti.   

Abstract

BACKGROUND: We investigated risk factors for inflammatory breast cancer (IBC), a rare, aggressive, and poorly understood breast cancer that is characterized by diffuse breast skin erythema and edema.
METHODS: We included 617 IBC case subjects in a nested case-control study from the Breast Cancer Surveillance Consortium database (1994-2009). We also included 1151 noninflammatory, locally advanced, invasive breast cancers with chest wall/breast skin involvement (LABC), 7600 noninflammatory invasive case subjects without chest wall/breast skin involvement (BC), and 93 654 control subjects matched to case subjects on age and year at diagnosis and mammography registry. We present estimates of rate ratios (RRs) and 95% confidence intervals (CI) from conditional logistic regression analyses for each case group vs control subjects based on multiply imputed datasets.
RESULTS: First-degree family history of breast cancer and high mammographic breast density increased risk of IBC, LABC, and BC. High body mass index (BMI) increased IBC risk irrespective of menopausal status and estrogen receptor (ER) expression; rate ratios for BMI 30 and greater vs BMI less than 25 were 3.90 (95% CI = 1.50 to 10.14) in premenopausal women and 3.70 (95% CI = 1.98 to 6.94) in peri/postmenopausal women not currently using hormones. BMI 30 and greater slightly increased risk of ER-positive BC (RR = 1.40; 95% CI = 1.11 to 1.76). Statistically significant reductions in risk of ER-negative IBC with older age at first birth and of ER-positive IBC with higher education were not seen for LABC and BC of the same ER status.
CONCLUSIONS: Different associations with BMI, age at first birth, and education between IBC and/or LABC and BC suggest a distinct etiology for IBC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24046390      PMCID: PMC3776263          DOI: 10.1093/jnci/djt206

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  14 in total

1.  Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database.

Authors:  R Ballard-Barbash; S H Taplin; B C Yankaskas; V L Ernster; R D Rosenberg; P A Carney; W E Barlow; B M Geller; K Kerlikowske; B K Edwards; C F Lynch; N Urban; C A Chrvala; C R Key; S P Poplack; J K Worden; L G Kessler
Journal:  AJR Am J Roentgenol       Date:  1997-10       Impact factor: 3.959

2.  Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer.

Authors:  Amanda I Phipps; Diana S M Buist; Kathleen E Malone; William E Barlow; Peggy L Porter; Karla Kerlikowske; Ellen S O'Meara; Christopher I Li
Journal:  Ann Epidemiol       Date:  2012-02-25       Impact factor: 3.797

3.  Expression of CD44 and E-cadherin cell adhesion molecules in hypertrophied bladders during chronic partial urethral obstruction and after release of partial obstruction in rats.

Authors:  Hayrettin Ozturk; Hulya Ozturk; Ensari Guneli; Yusuf Yagmur; Huseyin Buyukbayram
Journal:  Urology       Date:  2005-05       Impact factor: 2.649

4.  Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics.

Authors:  Lusine Yaghjyan; Graham A Colditz; Laura C Collins; Stuart J Schnitt; Bernard Rosner; Celine Vachon; Rulla M Tamimi
Journal:  J Natl Cancer Inst       Date:  2011-07-27       Impact factor: 13.506

5.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

6.  Association of inflammatory and noninflammatory breast cancer with socioeconomic characteristics in the Surveillance, Epidemiology, and End Results database, 2000-2007.

Authors:  Jennifer A Schlichting; Amr S Soliman; Catherine Schairer; Mousumi Banerjee; Laura S Rozek; David Schottenfeld; Joe B Harford; Sofia D Merajver
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-10-25       Impact factor: 4.254

Review 7.  Etiology of hormone receptor-defined breast cancer: a systematic review of the literature.

Authors:  Michelle D Althuis; Jennifer H Fergenbaum; Montserrat Garcia-Closas; Louise A Brinton; M Patricia Madigan; Mark E Sherman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-10       Impact factor: 4.254

8.  Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1995

Review 9.  Vascular endothelial growth factor and its relationship to inflammatory mediators.

Authors:  Laura S Angelo; Razelle Kurzrock
Journal:  Clin Cancer Res       Date:  2007-05-15       Impact factor: 12.531

10.  Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities?

Authors:  William F Anderson; Kenneth C Chu; Shine Chang
Journal:  J Clin Oncol       Date:  2003-06-15       Impact factor: 44.544

View more
  25 in total

1.  Diabetes, Abnormal Glucose, Dyslipidemia, Hypertension, and Risk of Inflammatory and Other Breast Cancer.

Authors:  Catherine Schairer; Shahinaz M Gadalla; Ruth M Pfeiffer; Steven C Moore; Eric A Engels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-01-13       Impact factor: 4.254

2.  Racial/ethnic disparities in inflammatory breast cancer survival in the Michigan Cancer Surveillance Program.

Authors:  Abdi T Gudina; Glenn Copeland; Amr S Soliman; Kelly A Hirko
Journal:  Breast Cancer Res Treat       Date:  2018-11-07       Impact factor: 4.872

3.  Breast cancer histologic subtypes show excess familial clustering.

Authors:  N Lynn Henry; Lisa A Cannon-Albright
Journal:  Cancer       Date:  2019-05-23       Impact factor: 6.860

Review 4.  How many etiological subtypes of breast cancer: two, three, four, or more?

Authors:  William F Anderson; Philip S Rosenberg; Aleix Prat; Charles M Perou; Mark E Sherman
Journal:  J Natl Cancer Inst       Date:  2014-08-12       Impact factor: 13.506

5.  BRCA mutations in women with inflammatory breast cancer.

Authors:  Angelica M Gutierrez Barrera; Tamer M Fouad; Juhee Song; Rachel Webster; Nisreen Elsayegh; Anita L Wood; Atakan Demir; Jennifer K Litton; Naoto T Ueno; Banu K Arun
Journal:  Cancer       Date:  2017-10-17       Impact factor: 6.860

6.  Inflammatory and other breast cancer incidence rate trends by estrogen receptor status in the Surveillance, Epidemiology, and End Results database (2001-2015).

Authors:  Sarah J Aurit; Susan S Devesa; Amr S Soliman; Catherine Schairer
Journal:  Breast Cancer Res Treat       Date:  2019-03-26       Impact factor: 4.872

7.  Differential effects of CD20+ B cells and PD-L1+ immune cells on pathologic complete response and outcome: comparison between inflammatory breast cancer and locally advanced breast cancer patients.

Authors:  Hugo Arias-Pulido; Ashley Marie Cimino-Mathews; Nabila Chaher; Clifford Ray Qualls; Nancy Joste; Cecile Colpaert; Jonathan Douglas Marotti; Mary Dickinson Chamberlin; Maxwell Gabriel Foisey; Eric Robert Prossnitz; Leisha Ann Emens; Steven Fiering
Journal:  Breast Cancer Res Treat       Date:  2021-09-20       Impact factor: 4.872

8.  Obesity and related conditions and risk of inflammatory breast cancer: a nested case-control study.

Authors:  Catherine Schairer; Cecile A Laurent; Lisa M Moy; Gretchen L Gierach; Neil E Caporaso; Ruth M Pfeiffer; Lawrence H Kushi
Journal:  Breast Cancer Res Treat       Date:  2020-07-20       Impact factor: 4.872

9.  Epidemiological risk factors associated with inflammatory breast cancer subtypes.

Authors:  Rachel L Atkinson; Randa El-Zein; Vicente Valero; Anthony Lucci; Therese B Bevers; Tamer Fouad; Weiqin Liao; Naoto T Ueno; Wendy A Woodward; Abenaa M Brewster
Journal:  Cancer Causes Control       Date:  2016-01-21       Impact factor: 2.506

Review 10.  New Treatment Strategies for the Inflammatory Breast Cancer.

Authors:  Elena Vagia; Massimo Cristofanilli
Journal:  Curr Treat Options Oncol       Date:  2021-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.